Newport Trust Company LLC Sells 15,058 Shares of Bath & Body Works, Inc. $BBWI

Key Points

• Newport Trust Company LLC has reduced its stake in Bath & Body Works by 4.7%, now owning approximately 0.14% of the company after selling 15,058 shares.
• Bath & Body Works is currently rated as a "Moderate Buy" by analysts with an average target price of $42.06, while multiple firms have lowered their target prices recently.
• The company announced a quarterly dividend of $0.20 per share, representing a yield of 2.7%, with the ex-dividend date set for August 22nd.

Newport Trust Company LLC decreased its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 4.7% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 302,650 shares of the company's stock after selling 15,058 shares during the quarter. Newport Trust Company LLC owned 0.14% of Bath & Body Works worth $9,176,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Golden State Wealth Management LLC raised its holdings in shares of Bath & Body Works by 94.7% in the first quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock worth $40,000 after buying an additional 642 shares during the period. UMB Bank n.a. raised its holdings in shares of Bath & Body Works by 65.9% in the first quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock worth $46,000 after buying an additional 596 shares during the period. Ancora Advisors LLC purchased a new stake in shares of Bath & Body Works in the fourth quarter worth approximately $67,000. GKV Capital Management Co. Inc. purchased a new stake in shares of Bath & Body Works in the first quarter worth approximately $69,000. Finally, Brooklyn Investment Group raised its holdings in shares of Bath & Body Works by 394.9% in the first quarter. Brooklyn Investment Group now owns 2,697 shares of the company's stock worth $82,000 after buying an additional 2,152 shares during the period. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

Bath & Body Works Stock Performance

BBWI traded up $1.6350 during trading on Friday, hitting $31.0550. 4,792,107 shares of the stock were exchanged, compared to its average volume of 4,664,486. The firm has a 50 day simple moving average of $30.30 and a 200 day simple moving average of $30.93. The firm has a market cap of $6.57 billion, a price-to-earnings ratio of 8.28, a P/E/G ratio of 1.04 and a beta of 1.54. Bath & Body Works, Inc. has a 1 year low of $24.94 and a 1 year high of $41.87.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its earnings results on Thursday, May 29th. The company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.47 by $0.02. The business had revenue of $1.40 billion for the quarter, compared to analysts' expectations of $1.42 billion. Bath & Body Works had a negative return on equity of 47.44% and a net margin of 11.10%.The business's revenue for the quarter was up 2.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.38 EPS. Bath & Body Works has set its Q2 2025 guidance at 0.330-0.380 EPS. As a group, equities analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, September 5th. Shareholders of record on Friday, August 22nd will be given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 2.6%. The ex-dividend date of this dividend is Friday, August 22nd. Bath & Body Works's dividend payout ratio (DPR) is 21.33%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the company. Piper Sandler set a $39.00 price target on Bath & Body Works and gave the stock an "overweight" rating in a report on Thursday, May 15th. Telsey Advisory Group reiterated an "outperform" rating and issued a $38.00 price target on shares of Bath & Body Works in a report on Thursday. UBS Group increased their price target on Bath & Body Works from $32.00 to $36.00 and gave the stock a "neutral" rating in a report on Tuesday, May 20th. JPMorgan Chase & Co. increased their price objective on Bath & Body Works from $40.00 to $46.00 and gave the stock an "overweight" rating in a research note on Monday, July 28th. Finally, Barclays reduced their price objective on Bath & Body Works from $35.00 to $30.00 and set an "equal weight" rating on the stock in a report on Friday, May 30th. Fourteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, Bath & Body Works presently has a consensus rating of "Moderate Buy" and a consensus price target of $42.06.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.